Diagnosing new-onset asthma in a paediatric clinical trial setting in school-age children
Diagnosing new-onset asthma in a paediatric clinical trial setting in school-age children
Asthma is a common chronic disease in children. It is a dynamic condition—symptoms change over time, and the outcome of diagnostic tests can vary. Consequently, evaluating the onset of asthma at a single point in time, perhaps when patients are asymptomatic with limited impairment of the lung function, may result in false diagnostic conclusions. The absence of consistent gold-standard diagnostic criteria in children challenges the ability of any study to ascertain an effect of treatment on asthma prevention. A comprehensive review of the diagnostic criteria used for new-onset asthma in school-age children was conducted based on existing recommendations from published clinical guidance, alongside evidence from paediatric asthma prevention trials. Findings from the review were used to propose suggestions for diagnosing new-onset asthma in future asthma prevention trials. Despite an overall lack of consensus in the published clinical guidance, there are similarities between the various recommendations for diagnosing asthma in children, which typically involve assessing the variable symptoms and supplementing the medical history with objective measures of lung function. For future paediatric asthma prevention trials, we suggest that paediatric clinical trials should use a new-onset asthma definition that incorporates the concepts of “possible”, “probable” and “confirmed” asthma. “Possible” asthma would capture self-reported features of chronic symptoms and symptom relief with β2-agonist bronchodilator (suggesting reversibility). “Probable” asthma would include symptom chronicity, self-reported symptom relief with β2-agonist bronchodilator, and objective features of asthma (reversibility or bronchial hyper-responsiveness). A “confirmed” diagnosis would be made only if there is a positive response to controller therapy. These suggestions aim to improve the diagnosis of new-onset childhood asthma in clinical trials, which will be useful in the design and conduct of future paediatric asthma prevention trials.
allergen immunotherapy, children, clinical trials, diagnosis, new-onset asthma
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Valovirta, Erkka
ef88c572-ca23-4dce-8026-0b0e142ab024
Halken, Susanne
2d3b1100-70d1-46e1-8466-15990d478a9f
Eng, Peter A.
a8777b98-07e8-4cd4-8562-cd3a584b853b
Mäkelä, Mika J.
ae07b46c-4c1d-4e30-9a1c-24e3f5bcb6f6
Lødrup Carlsen, Karin C.
87b1f133-e43e-473f-8401-3ce31c2ddd81
Knecht, Roland
92f37e9b-24e5-4693-ab2b-85bf4c11db19
Malmberg, L. Pekka
cefc7979-0d51-455b-8dea-b2b8b0253066
15 July 2024
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Valovirta, Erkka
ef88c572-ca23-4dce-8026-0b0e142ab024
Halken, Susanne
2d3b1100-70d1-46e1-8466-15990d478a9f
Eng, Peter A.
a8777b98-07e8-4cd4-8562-cd3a584b853b
Mäkelä, Mika J.
ae07b46c-4c1d-4e30-9a1c-24e3f5bcb6f6
Lødrup Carlsen, Karin C.
87b1f133-e43e-473f-8401-3ce31c2ddd81
Knecht, Roland
92f37e9b-24e5-4693-ab2b-85bf4c11db19
Malmberg, L. Pekka
cefc7979-0d51-455b-8dea-b2b8b0253066
Roberts, Graham, Valovirta, Erkka, Halken, Susanne, Eng, Peter A., Mäkelä, Mika J., Lødrup Carlsen, Karin C., Knecht, Roland and Malmberg, L. Pekka
(2024)
Diagnosing new-onset asthma in a paediatric clinical trial setting in school-age children.
Frontiers in Allergy, 5, [1418922].
(doi:10.3389/falgy.2024.1418922).
Abstract
Asthma is a common chronic disease in children. It is a dynamic condition—symptoms change over time, and the outcome of diagnostic tests can vary. Consequently, evaluating the onset of asthma at a single point in time, perhaps when patients are asymptomatic with limited impairment of the lung function, may result in false diagnostic conclusions. The absence of consistent gold-standard diagnostic criteria in children challenges the ability of any study to ascertain an effect of treatment on asthma prevention. A comprehensive review of the diagnostic criteria used for new-onset asthma in school-age children was conducted based on existing recommendations from published clinical guidance, alongside evidence from paediatric asthma prevention trials. Findings from the review were used to propose suggestions for diagnosing new-onset asthma in future asthma prevention trials. Despite an overall lack of consensus in the published clinical guidance, there are similarities between the various recommendations for diagnosing asthma in children, which typically involve assessing the variable symptoms and supplementing the medical history with objective measures of lung function. For future paediatric asthma prevention trials, we suggest that paediatric clinical trials should use a new-onset asthma definition that incorporates the concepts of “possible”, “probable” and “confirmed” asthma. “Possible” asthma would capture self-reported features of chronic symptoms and symptom relief with β2-agonist bronchodilator (suggesting reversibility). “Probable” asthma would include symptom chronicity, self-reported symptom relief with β2-agonist bronchodilator, and objective features of asthma (reversibility or bronchial hyper-responsiveness). A “confirmed” diagnosis would be made only if there is a positive response to controller therapy. These suggestions aim to improve the diagnosis of new-onset childhood asthma in clinical trials, which will be useful in the design and conduct of future paediatric asthma prevention trials.
Text
falgy-05-1418922
- Version of Record
More information
Accepted/In Press date: 21 May 2024
Published date: 15 July 2024
Keywords:
allergen immunotherapy, children, clinical trials, diagnosis, new-onset asthma
Identifiers
Local EPrints ID: 493655
URI: http://eprints.soton.ac.uk/id/eprint/493655
ISSN: 2673-6101
PURE UUID: 15e36c1b-5ac9-4fa2-84d6-3af0c8ed676b
Catalogue record
Date deposited: 10 Sep 2024 16:36
Last modified: 11 Sep 2024 01:43
Export record
Altmetrics
Contributors
Author:
Erkka Valovirta
Author:
Susanne Halken
Author:
Peter A. Eng
Author:
Mika J. Mäkelä
Author:
Karin C. Lødrup Carlsen
Author:
Roland Knecht
Author:
L. Pekka Malmberg
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics